Cell cycle |
124 |
16.3 |
40 |
40 |
2.18E-08 |
6.92E-06 |
Oocyte meiosis |
125 |
16.4 |
36 |
36 |
2.41E-06 |
0.000383 |
DNA replication |
36 |
4.72 |
15 |
15 |
1.97E-05 |
0.00209 |
One carbon pool by folate |
20 |
2.62 |
10 |
10 |
7.61E-05 |
0.00605 |
Mismatch repair |
23 |
3.01 |
9 |
9 |
0.00161 |
0.102 |
Amphetamine addiction |
68 |
8.91 |
18 |
18 |
0.00228 |
0.12 |
Neurotrophinsignaling pathway |
119 |
15.6 |
27 |
27 |
0.00265 |
0.12 |
Biosynthesis of amino acids |
75 |
9.83 |
19 |
19 |
0.00301 |
0.12 |
Progesterone-mediated oocyte maturation |
99 |
13 |
23 |
23 |
0.00388 |
0.125 |
Spliceosome |
134 |
17.6 |
29 |
29 |
0.00393 |
0.125 |
Long-term potentiation |
67 |
8.78 |
17 |
17 |
0.00479 |
0.133 |
Melanogenesis |
101 |
13.2 |
23 |
23 |
0.00505 |
0.133 |
Pyrimidine metabolism |
57 |
7.47 |
15 |
15 |
0.00545 |
0.133 |
RNA transport |
165 |
21.6 |
33 |
33 |
0.00786 |
0.179 |
Legionellosis |
55 |
7.21 |
14 |
14 |
0.00971 |
0.205 |
Dopaminergic synapse |
131 |
17.2 |
27 |
27 |
0.0103 |
0.205 |
Amoebiasis |
96 |
12.6 |
21 |
21 |
0.0115 |
0.206 |
Citrate cycle (TCA cycle) |
30 |
3.93 |
9 |
9 |
0.0121 |
0.206 |
mRNA surveillance pathway |
91 |
11.9 |
20 |
20 |
0.0127 |
0.206 |
Glucagon signaling pathway |
103 |
13.5 |
22 |
22 |
0.013 |
0.206 |
TNF signaling pathway |
110 |
14.4 |
23 |
23 |
0.0144 |
0.206 |
Alanine, aspartate and glutamate metabolism |
36 |
4.72 |
10 |
10 |
0.0147 |
0.206 |
Renin secretion |
69 |
9.04 |
16 |
16 |
0.0149 |
0.206 |
Nucleotide excision repair |
47 |
6.16 |
12 |
12 |
0.0157 |
0.208 |
HTLV-I infection |
219 |
28.7 |
40 |
40 |
0.0171 |
0.218 |
Gap junction |
88 |
11.5 |
19 |
19 |
0.0179 |
0.219 |
Signaling pathways regulating pluripotency of stem cells |
139 |
18.2 |
27 |
27 |
0.0218 |
0.251 |
Base excision repair |
33 |
4.32 |
9 |
9 |
0.0227 |
0.251 |
2-Oxocarboxylic acid metabolism |
18 |
2.36 |
6 |
6 |
0.0229 |
0.251 |
Circadian entrainment |
97 |
12.7 |
20 |
20 |
0.0248 |
0.263 |
IL-17 signaling pathway |
93 |
12.2 |
19 |
19 |
0.0308 |
0.303 |
GnRHsignaling pathway |
93 |
12.2 |
19 |
19 |
0.0308 |
0.303 |
Ubiquitin mediated proteolysis |
137 |
18 |
26 |
26 |
0.0315 |
0.303 |
Kaposi’s sarcoma-associated herpesvirus infection |
186 |
24.4 |
33 |
33 |
0.041 |
0.351 |
Autophagy - animal |
128 |
16.8 |
24 |
24 |
0.0427 |
0.351 |
Osteoclast differentiation |
128 |
16.8 |
24 |
24 |
0.0427 |
0.351 |
Valine, leucine and isoleucine degradation |
48 |
6.29 |
11 |
11 |
0.0428 |
0.351 |
Fanconianemia pathway |
54 |
7.08 |
12 |
12 |
0.0437 |
0.351 |
p53 signaling pathway |
72 |
9.44 |
15 |
15 |
0.044 |
0.351 |
Chagas disease (American trypanosomiasis) |
103 |
13.5 |
20 |
20 |
0.0442 |
0.351 |
EGFR tyrosine kinase inhibitor resistance |
79 |
10.4 |
16 |
16 |
0.0482 |
0.37 |
Cocaine addiction |
49 |
6.42 |
11 |
11 |
0.0489 |
0.37 |